Search research articles
Contact Us
Filters
Showing results (101-110 of 145) with videos related to
Page
of 15
Sort By:
JAMA Neurology
|
August 21, 2023
Teriflunomide and Time to Clinical Multiple Sclerosis in Patients With Radiologically Isolated Syndrome: The TERIS Randomized Clinical Trial
Christine Lebrun-Frénay, Aksel Siva, Maria Pia Sormani, et al.
Neurology
|
April 1, 2026
Diagnostic Value of the Kappa Free Light Chain Index to Distinguish MOGAD, NMOSD, and MS
Apolline Tournier, Antoine Gavoille, Julie Pique, et al.
BMC Neurology
|
October 28, 2025
Influence of geographical accessibility to specialist and primary care givers on excess mortality of multiple sclerosis patients in France
Sarah Wilson, Emmanuelle Leray, Floriane Calocer, et al.
Journal of Neurology
|
April 25, 2019
Pathologic and MRI analysis in acute atypical inflammatory demyelinating lesions
Xavier Ayrignac, Valérie Rigau, Benoit Lhermitte, et al.
JAMA
|
March 10, 2025
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial
Eric Thouvenot, David Laplaud, Christine Lebrun-Frenay, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
June 1, 2019
Frequency and characteristics of short versus longitudinally extensive myelitis in adults with MOG antibodies: A retrospective multicentric study
Jonathan Ciron, Alvaro Cobo-Calvo, Bertrand Audoin, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
February 11, 2025
Assessing the Risk of Relapse After In Vitro Fertilization in Women With Multiple Sclerosis
Marie Mainguy, Romain Casey, Sandra Vukusic, et al.
Brain : a Journal of Neurology
|
June 30, 2026
Blood cytotoxic natural killer-like CD8 + CD94+ T cells migrate to the brain and predict multiple sclerosis severity
Emilie Dugast, Sita Shah, Isabel Vogel, et al.
Neurology
|
January 31, 2016
Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study
Laetitia Barbin, Chloe Rousseau, Natacha Jousset, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
February 26, 2022
Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing-Remitting Multiple Sclerosis After Fingolimod Withdrawal
Fabien Rollot, Justine Couturier, Romain Casey, et al.
Page
of 15
Search research articles
Search
Showing results (101-110 of 145) with videos related to
Sort By:
Page
of 15
JAMA Neurology
|
August 21, 2023
Teriflunomide and Time to Clinical Multiple Sclerosis in Patients With Radiologically Isolated Syndrome: The TERIS Randomized Clinical Trial
Christine Lebrun-Frénay, Aksel Siva, Maria Pia Sormani, et al.
Neurology
|
April 1, 2026
Diagnostic Value of the Kappa Free Light Chain Index to Distinguish MOGAD, NMOSD, and MS
Apolline Tournier, Antoine Gavoille, Julie Pique, et al.
BMC Neurology
|
October 28, 2025
Influence of geographical accessibility to specialist and primary care givers on excess mortality of multiple sclerosis patients in France
Sarah Wilson, Emmanuelle Leray, Floriane Calocer, et al.
Journal of Neurology
|
April 25, 2019
Pathologic and MRI analysis in acute atypical inflammatory demyelinating lesions
Xavier Ayrignac, Valérie Rigau, Benoit Lhermitte, et al.
JAMA
|
March 10, 2025
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial
Eric Thouvenot, David Laplaud, Christine Lebrun-Frenay, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
June 1, 2019
Frequency and characteristics of short versus longitudinally extensive myelitis in adults with MOG antibodies: A retrospective multicentric study
Jonathan Ciron, Alvaro Cobo-Calvo, Bertrand Audoin, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
February 11, 2025
Assessing the Risk of Relapse After In Vitro Fertilization in Women With Multiple Sclerosis
Marie Mainguy, Romain Casey, Sandra Vukusic, et al.
Brain : a Journal of Neurology
|
June 30, 2026
Blood cytotoxic natural killer-like CD8 + CD94+ T cells migrate to the brain and predict multiple sclerosis severity
Emilie Dugast, Sita Shah, Isabel Vogel, et al.
Neurology
|
January 31, 2016
Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study
Laetitia Barbin, Chloe Rousseau, Natacha Jousset, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
February 26, 2022
Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing-Remitting Multiple Sclerosis After Fingolimod Withdrawal
Fabien Rollot, Justine Couturier, Romain Casey, et al.
Page
of 15